Is CVE-2026-24164 in the CISA KEV catalog?

No. CVE-2026-24164 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2026-24164?

CVE-2026-24164 has a CVSS v3 base score of 8.8 (HIGH).

What is the EPSS score for CVE-2026-24164?

CVE-2026-24164 has an EPSS score of 0.47% (37th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2026-24164

HIGH

8.8

CVSS v3

NVD

Description

NVIDIA BioNeMo contains a vulnerability where a user could cause a deserialization of untrusted data. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CWE-502Deserialization of Untrusted Data

CVSS v3 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges RequiredNone

User InteractionRequired

ScopeUnchanged

Impact

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Exploit Intelligence

0.47%probability of exploitation in 30 days

37thpercentile

Low risk: more likely to be exploited than 37% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-04-03.